Accenture Launches Offering to Help Health Insurers Enhance the Customer Experience and Deliver Long-Term Growth

Go back to Accenture Launches Offering to Help Health Insurers Enhance the Customer Experience and Deliver Long-Term Growth

UBS Raises Price Target on Accenture (ACN) to $125; Remains Sidelined

September 30, 2016 8:59 AM EDT

UBS reiterated a Neutral rating on Accenture plc (NYSE: ACN), and raised the price target to $125.00 (from $115.00), following the company's 4Q earnings report.

Analyst Michael Briest commented, "Accenture closed out 2016 with a strong 9% growth rate in Q4, led by Products (+18%), which is... More